Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Abnormalities”

3,346 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,346 results

Not applicableStudy completedNCT05890833
What this trial is testing

The Risk of Falls Index for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyFacioscapulohumeral Muscular Dystrophies+3 more
LMU Klinikum 30
Not applicableLooking for participantsNCT04826744
What this trial is testing

Frequency of Palpebral Involvement in Adult With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
University Hospital, Lille 550
Not applicableLooking for participantsNCT04784364
What this trial is testing

Biologics And Clinical Immunology Cohort at Sinai

Who this might be right for
Immunological DiseaseAutoimmune DiseasesPrimary Immune Deficiency
Icahn School of Medicine at Mount Sinai 800
Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Large-scale testing (Phase 3)Study completedNCT01963143
What this trial is testing

Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases

Who this might be right for
Primary Immune Deficiency DisordersCommon Variable ImmunodeficiencyX-linked Agammaglobulinaemia+1 more
Bio Products Laboratory 48
Large-scale testing (Phase 3)Study completedNCT03961529
What this trial is testing

Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Otsuka Pharmaceutical Co., Ltd. 366
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Not applicableStudy completedNCT02906475
What this trial is testing

Atopic Dermatitis in Atopy Predisposed Infants

Who this might be right for
Dermatitis, Atopic
HiPP GmbH & Co. Vertrieb KG 160
Post-approval studies (Phase 4)Not Yet RecruitingNCT07308964
What this trial is testing

Comparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye Disease

Who this might be right for
Thyroid Eye DiseaseThyroid Eye Disease, TEDThyroid Eye Disease (TED)
Sheba Medical Center 40
Not applicableStudy completedNCT01897506
What this trial is testing

Assessing Risk of Food Insecurity Within Households of Children With Food Allergy

Who this might be right for
Food AllergyAsthmaAllergic Rhinitis+2 more
Arkansas Children's Hospital Research Institute 650
Not applicableStudy completedNCT06585592
What this trial is testing

Establishment of Multimodal-multiparametric Progressive Prediction Models for Thyroid Associated Ophthalmopathy

Who this might be right for
Thyroid-Associated Ophthalmopathy
Shanghai Changzheng Hospital 500
Early research (Phase 1)Study completedNCT06248814
What this trial is testing

Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Bristol-Myers Squibb 64
Testing effectiveness (Phase 2)Study completedNCT01441076
What this trial is testing

Anakinra for Behcet s Disease

Who this might be right for
Autoimmune Connective Tissue DisorderImmune System Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 6
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Testing effectiveness (Phase 2)Study completedNCT03921411
What this trial is testing

A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Galderma R&D 20
Post-approval studies (Phase 4)Study completedNCT00001317
What this trial is testing

A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Not applicableStudy completedNCT00086476
What this trial is testing

Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles

Who this might be right for
Blood Coagulation Disorders
National Human Genome Research Institute (NHGRI) 3
Large-scale testing (Phase 3)Study completedNCT05633355
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 187
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Load More Results